These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16633504)

  • 61. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
    Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
    Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya.
    Goodman CA; Mutemi WM; Baya EK; Willetts A; Marsh V
    Health Policy Plan; 2006 Jul; 21(4):275-88. PubMed ID: 16682433
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reducing the burden of affective disorders: is evidence-based health care affordable?
    Sanderson K; Andrews G; Corry J; Lapsley H
    J Affect Disord; 2003 Nov; 77(2):109-25. PubMed ID: 14607388
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.
    Ochalek J; Lomas J
    Clin Ther; 2020 Jan; 42(1):44-59.e2. PubMed ID: 31955967
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessing cost-effectiveness in mental health: family interventions for schizophrenia and related conditions.
    Mihalopoulos C; Magnus A; Carter R; Vos T
    Aust N Z J Psychiatry; 2004 Jul; 38(7):511-9. PubMed ID: 15255823
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.
    Vos T; Corry J; Haby MM; Carter R; Andrews G
    Aust N Z J Psychiatry; 2005 Aug; 39(8):683-92. PubMed ID: 16050922
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost-effectiveness of malaria control in sub-Saharan Africa.
    Goodman CA; Coleman PG; Mills AJ
    Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An economic case study of the control of dog-mediated rabies by an animal welfare organisation in Jaipur, India.
    Larkins AJ; Reece JF; Shaw APM; Thrusfield MV
    Prev Vet Med; 2020 Oct; 183():105120. PubMed ID: 32890917
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost-effectiveness analysis of parenting interventions for the prevention of behaviour problems in children.
    Nystrand C; Feldman I; Enebrink P; Sampaio F
    PLoS One; 2019; 14(12):e0225503. PubMed ID: 31790442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives.
    Streatfeild J; Hillman D; Adams R; Mitchell S; Pezzullo L
    Sleep; 2019 Dec; 42(12):. PubMed ID: 31403163
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.
    Baral R; Nonvignon J; Debellut F; Agyemang SA; Clark A; Pecenka C
    BMC Public Health; 2020 May; 20(1):619. PubMed ID: 32370763
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis.
    Bertram MY; Chisholm D; Watts R; Waqanivalu T; Prasad V; Varghese C
    Int J Health Policy Manag; 2021 Nov; 10(11):724-733. PubMed ID: 34273918
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
    Patel HD; Roberts ET; Constenla DO
    Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Economic Evaluation of an Intervention Designed to Reduce Bullying in Australian Schools.
    Jadambaa A; Graves N; Cross D; Pacella R; Thomas HJ; Scott JG; Cheng Q; Brain D
    Appl Health Econ Health Policy; 2022 Jan; 20(1):79-89. PubMed ID: 34368934
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi.
    Niyibitegeka F; Thavorncharoensap M; Riewpaiboon A; Youngkong S
    Appl Health Econ Health Policy; 2022 Sep; 20(5):707-716. PubMed ID: 35469393
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.